Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pateclizumab

Known as: MLTA3698A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BackgroundThe role of tumor necrosis factor (TNF) in the inflammatory response in rheumatoid arthritis (RA) is well established… Expand
  • figure 1
  • figure 2
Is this relevant?
2016
2016
An enhanced embryo-fetal development study was conducted in cynomolgus monkeys using pateclizumab, a humanized IgG1 monoclonal… Expand
Is this relevant?
2014
2014
IntroductionTumor necrosis factor (TNF) and, possibly, lymphotoxin alpha (LTα) signaling contribute to inflammation and… Expand
  • table 1
  • table 3
  • table 2
  • table 4
  • figure 1
Is this relevant?
2013
2013
Background Pateclizumab (formerly MLTA3698A), a novel humanized IgG1 antibody against soluble and membrane isoforms of… Expand
Is this relevant?
2013
2013
Background Lymphotoxin (LT)-α, a member of the TNF superfamily, is required for lymph node development and recruitment of B and T… Expand
Is this relevant?
2012
2012
IntroductionPateclizumab (MLTA3698A) is a humanized mAb against lymphotoxin α (LTα), a transiently expressed cytokine on… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2012
2012
Graft-versus-host disease (GVHD) is a major barrier to successful allogeneic hematopoietic cell transplantation and is largely… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?